EurekAlert! -
10 Feb 2021 07:00
(The Lundquist Institute ) The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. This innovative and first-of-its-kind psychedelic study will be conducted at several leading medical schools and cancer centers across the United States, including Harbor-UCLA ...
Share this Article